This technology provides a composition for inducing neuroectodermal differentiation of stem cells, comprising a TGF-β receptor ALK5 inhibitor, a BMP inhibitor, and an MMP inhibitor.
There was a need for a method to efficiently differentiate stem cells into specific cells for cell therapy.
This technology enhances differentiation efficiency by treating human embryonic and induced pluripotent stem cells with three types of inhibitors, which promotes neuroectodermal differentiation.
N/A